Michael Anderson Burley

Nerd with a wild streak. Michael trades his craft from three main baskets: biotechnology, innovation & entrepreneurship, and strategic consulting. He has failed in a medtech start-up, consulted for start-ups in the Cambridge biocluster and for senior leadership in a 350 year old science & technology company. He helped build up Merck´s Innovation Centre, was recruited into their first Think Tank (synthetic biology) and subsequently co-founded their first Innovation Centre project (enzymatic DNA synthesis) where he led technology development and commercial strategy. Now he leads business development across Europe for Merck´s Life Science Research portfolio. Michael studied biotechnology at Imperial College London and bioscience enterprise at Cambridge University, where he is now a guest lecturer.